DOK5 and lung adenocarcinoma: However, DOK5 expression was significantly increased in cholangiocarcinoma (CHOL), liver hepatocellular carcinoma (LIHC), lung adenocarcinoma (LUAD), and stomach adenocarcinoma (STAD), compared to adjacent normal tissues.